# Effect of Systemic Ropivacaine on Hyperalgesia, Flare Reaction and Peripheral Nerve Excitability

> **NCT00900913** · PHASE4 · COMPLETED · sponsor: **University of Zurich** · enrollment: 34 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ropivacaine (Naropin)

## Key facts

- **NCT ID:** NCT00900913
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-07
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2011-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00900913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00900913, "Effect of Systemic Ropivacaine on Hyperalgesia, Flare Reaction and Peripheral Nerve Excitability". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00900913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*